Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Dev Dyn. 2013 Feb;242(2):108–121. doi: 10.1002/dvdy.23906

Figure 5. VPA inhibits primitive erythroid progenitor emergence in mouse yolk sac explants.

Figure 5

A) EryP-CFC (mean ± SEM) per 1000 yolk sac explant cells cultured in vitro for 48 hours with 0, 0.4, and 0.8 mM VPA. B) Number of live cells (mean ± SEM) per yolk sac explant with 0, 0.4, and 0.8 mM VPA.